Human papillomavirus and gastrointestinal cancer: A review

World J Gastroenterol. 2016 Sep 7;22(33):7415-30. doi: 10.3748/wjg.v22.i33.7415.

Abstract

Human papillomavirus (HPV) is one of the most common sexually transmitted infections worldwide. Exposure to HPV is very common, and an estimated 65%-100% of sexually active adults are exposed to HPV in their lifetime. The majority of HPV infections are asymptomatic, but there is a 10% chance that individuals will develop a persistent infection and have an increased risk of developing a carcinoma. The International Agency for Research on Cancer has found that the following cancer sites have a strong causal relationship with HPV: cervix uteri, penis, vulva, vagina, anus and oropharynx, including the base of the tongue and the tonsils. However, studies of the aetiological role of HPV in colorectal and esophageal malignancies have conflicting results. The aim of this review was to organize recent evidence and issues about the association between HPV infection and gastrointestinal tumours with a focus on esophageal, colorectal and anal cancers. The ultimate goal was to highlight possible implications for prognosis and prevention.

Keywords: Anal cancer; Colorectal cancer; Esophageal cancer; Human papillomavirus; Oncogenesis; Prevention; Prognosis.

Publication types

  • Review

MeSH terms

  • Anus Neoplasms / virology*
  • Carcinogenesis
  • Colorectal Neoplasms / virology*
  • Disease Progression
  • Esophageal Neoplasms / virology*
  • Humans
  • Immunosuppression Therapy
  • Papillomaviridae*
  • Papillomavirus Infections / virology*
  • Papillomavirus Vaccines / therapeutic use*
  • Prognosis
  • Risk
  • Vaccination

Substances

  • Papillomavirus Vaccines